Hematologic Neoplasms: Clinical Trials

14 trials for Hematologic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 unknown. 14 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Unknown 14
Phase 23Unknown 3

Follow Hematologic Neoplasms: new trials by email Literature Review of Hematologic Neoplasms trials Research Report on Hematologic Neoplasms

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia
Phase 3UnknownZhongnan Hospital1682023-02-072023-08-25
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
Aminoglycosides intervention, Lack of protective isolation intervention, No systematic aminoglycosides intervention - standard arm - Sepsis, Septic Shock
Phase 3UnknownAssistance Publique - Hôpitaux de Paris3402022-09-012022-07-05
Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis
Post-transplantation Cyclophosphamide at dose 25 mg/kg/day, Post-transplantation Cyclophosphamide at dose 50 mg/kg/day - Graft Versus Host Disease, Hematologic Malignancy
Phase 3UnknownNational Research Center for Hematology, Russia1002022-01-012022-01-11
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
Azacitidine, all trans retinoic acid - AML, MDS
Phase 2 / Phase 3UnknownThe First Affiliated Hospital of Soochow University1802021-05-012022-01-03
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer) - Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms
Phase 3UnknownUniversity of Liege502021-03-222022-05-18
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
CAR-T cell therapy - Hematological Malignancy
Phase 2 / Phase 3UnknownShanxi Bethune Hospital302020-06-152024-02-02
Early Palliative Care for Patients With Haematological Malignancies
Early palliative care integration - Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 3UnknownUniversity Hospital, Clermont-Ferrand1402019-03-142021-03-24
Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT
Imipenem - Antibacterial Prophylaxis, Hematological Malignancies
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University2502018-12-012018-11-07
Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells
T-reg depleted DLI, Standard DLI - Hematological Malignancies, Regulatory T Cell Depletion
Phase 3UnknownAssistance Publique - Hôpitaux de Paris522018-02-222023-12-18
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
Methylprednisolone, Placebo - Pneumocystis, Steroids
Phase 3UnknownAssistance Publique - Hôpitaux de Paris2222017-02-152020-10-06
Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation?
Low level laser therapy - Oral Mucositis, Effects of Chemotherapy
Phase 3UnknownInstituto Materno Infantil Prof. Fernando Figueira362015-01-012013-12-25
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Anti-Thymocyte Globulin (Rabbit), Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) - Hematologic Malignancies
Phase 3UnknownMcMaster University1982010-04-012010-10-08
Exercise During Chemotherapy for Patients With Hematological Malignancies
Aerobic exercise, Fatigue counseling - Hematological Diseases, Hematological Malignancies
Phase 3UnknownCharite University, Berlin, Germany602009-05-012009-12-23
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer
Phase 3UnknownUniversity of Glasgow2142009-04-012011-05-13

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Myelodysplastic Syndromes (3)  ·  Neoplasms (3)  ·  Hodgkin Disease (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Multiple Myeloma (2)  ·  Myeloproliferative Disorders (2)  ·  Anxiety Disorders (1)  ·  Blast Crisis (1)  ·  Bone Marrow Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  COVID-19 (1)

Broader conditions

Hemic and Lymphatic Diseases (14)  ·  Neoplasms by Site (14)  ·  Hematologic Diseases (13)  ·  Neoplasms (11)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Bone Marrow Diseases (5)  ·  Immune System Diseases (5)  ·  Neoplasms by Histologic Type (5)  ·  Pathologic Processes (5)  ·  Immunoproliferative Disorders (4)  ·  Infections (4)  ·  Leukemia (4)  ·  Leukemia, Myeloid (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)

Interventions

Antilymphocyte Serum (1)  ·  Azacitidine (1)  ·  BNT162 Vaccine (1)  ·  CVnCoV COVID-19 vaccine (1)  ·  Cyclophosphamide (1)  ·  Exercise (1)  ·  Imipenem (1)  ·  Immunotherapy, Adoptive (1)  ·  Ketamine (1)  ·  Low-Level Light Therapy (1)  ·  Methylprednisolone (1)  ·  Pharmacogenomic Testing (1)  ·  Tretinoin (1)  ·  ferrous succinate (1)  ·  shengxuening (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  Charite University, Berlin, Germany (1)  ·  Instituto Materno Infantil Prof. Fernando Figueira (1)  ·  McMaster University (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  National Research Center for Hematology, Russia (1)  ·  Shanxi Bethune Hospital (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Glasgow (1)  ·  University of Liege (1)  ·  Zhongnan Hospital (1)

Countries

China (4)  ·  France (3)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Barry J.A. Laird, MD (1)  ·  Elena Parovichnikova, MD, D.Sc (1)  ·  Elie Azoulay, MD PHD (1)  ·  Fernando Dimeo, MD (1)  ·  Flavia A de Orange, PhD (1)  ·  Han Yue, Ph.D (1)  ·  Irwin Walker, MD (1)  ·  Liu Qifa (1)  ·  Marie T. Fallon (1)  ·  Virginie Lemiale, MD (1)  ·  Xiaomin Zhang (1)

Results publications

PMID 31756535, PMID 31958417, PMID 37341189, PMID 40652952, PMID 42558999

NIH funding

2016 (1)